Presidential address: The foundations of modern aortic surgery  by Smith III, Robert B.
7“The farther backward you can look, the farther for-
ward you are likely to see.”
—Sir Winston Churchill
It is a high privilege to have served as President
of the North American Chapter of the International
Society for Cardiovascular Surgery for the past year,
quite an eventful one in our specialty. Please permit
me to begin by expressing a few words of apprecia-
tion to persons who have been important to my pro-
fessional career over the past 40 years: to my men-
tors during residency at the Columbia-Presbyterian
Medical Center, especially the late Arthur B.
Voorhees, Jr.; to my senior colleague at Emory for
many years, Garland Perdue; to other faculty associ-
ates in the Division of Vascular Surgery at Emory; to
our 34 vascular surgery trainees, many of whom are
present here today; and, finally, to my own family,
especially my wife, Flo, without whose support and
forbearance it would not have been possible, and
certainly not as much fun. Indeed, I am also indebt-
ed to every colleague in this room for your enrich-
ment of the discipline of vascular surgery, our cho-
sen life’s work.
Now, to the subject at hand, the foundations of
modern aortic surgery. As some of you know, the
history of vascular surgery has been one of my inter-
ests for a number of years, sparked, I am sure, by
friendship during training and in subsequent years
with Arthur Voorhees, one of the true innovators of
surgery.1 I have been fortunate that my own profes-
sional career has spanned almost the entire modern
period of our specialty, since I graduated from med-
ical school exactly 40 years ago this month. For
some time I have felt that the current generation of
young vascular surgeons should have a better knowl-
edge of the birth and early maturation of modern
vascular surgery to appreciate more fully the contri-
butions of our pioneers. Standard infrarenal aortic
aneurysm repair has become almost routine to vas-
cular trainees of the 1990s. With expert anesthesia,
superior instruments, reliable prostheses, autoinfu-
sion devices, and critical care units, most aortic oper-
ations are performed expeditiously, and the patients
recover uneventfully and are discharged on the
appropriate day as defined by their clinical pathway.
Believe me, the early days of aortic surgery were not
so routine or predictable. Some colleagues here
today, maybe even a few senior to me in years of
practice, can well remember the courage, persever-
ance, and self-sacrifice necessary for both the sur-
geon and the patient to undertake aortic surgery in
those early days. It is exactly that period in our his-
tory to which I wish to focus your attention this
morning.
In preparation for this talk, I have consulted the
literature, of course, but I have also been privileged
to interview a number of senior surgeons who were
important contributors in the decades of the 1950s
and 1960s. In addition, I have been able to visit the
headquarters of several of the largest graft fabricators
in the industry. Finally, through the generosity of
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Art Voorhees’ widow, Margaret, I have received
trusteeship of his slide collection and other memora-
bilia of his career. For all of these various opportuni-
ties, I am deeply grateful. Before proceeding, I must
pause to commend to you two recently published
books on the history of vascular surgery: Band of
Brothers, conceived and started by Andrew Dale
before his death and finished by his associates,
George Johnson and James DeWeese, and Clio: The
Arteries, an encyclopedic work compiled by Wiley
Barker.2,3 I must also express one proviso. There is
always the possibility in a presentation of this type
that the speaker will fail to include an important
contributor or to ascribe sufficient primacy to his
work—for any such failings, I apologize in advance.
Finally, I would be remiss if I did not acknowledge
the invaluable assistance of Jesse Thompson in the
quest for historical accuracy.
Before we jump directly to the middle of this
century, allow me to back up long enough to
describe some of the earlier foundations of our dis-
cipline. Those of you who have visited the ancient
cities of Jerusalem or Luxor know that many mod-
ern sites are built on foundations of previous civi-
lizations (Figs. 1 and 2). Such is the case with mod-
ern vascular surgery, as well. It is safe to assume that
among the foundations of vascular surgery one must
include the seminal work of Carrel and Guthrie,
early in this century at the University of Chicago,
and later at the Rockefeller Institute, where Carrel
performed homograft aortic replacements and other
vascular procedures on experimental animals.4-6 For
his pioneering achievements in vascular surgery and
organ transplantation, Alexis Carrel was awarded the
Nobel Prize for Physiology and Medicine in 1912.
Jose Goyanes7 of Madrid had performed the first
successful replacement of a human artery in 1906,
which was a venous autograft to bridge an excised
popliteal aneurysm. Reynaldo Dos Santos8 of
Portugal subsequently reported angiographic visual-
ization of the abdominal aorta and runoff vessels in
1929.
Aortic surgery, largely impossible to consider
before that time, took a leap forward in 1923, when
Rudolph Matas9 of New Orleans performed success-
ful ligation of the infrarenal aorta for a leaking luet-
ic aneurysm, truly an incredible technical feat for the
period. In the same year, Rene Leriche, the most
noted French vascular surgeon of his day, stated:
“The ideal treatment of arterial thrombosis is the
replacement of the obstructed segment with a vas-
cular graft.”10 This was the same Leriche who 17
years later described the syndrome of occlusive dis-
ease of the terminal abdominal aorta that carries his
name.11
In the decade before World War II, a variety of
bold attempts were made by surgeons to treat
patients who were threatened by enlarging aortic
aneurysms or progressive thrombosis of the terminal
aorta. Rigid tubes made from a variety of materials
had been used for years in an effort to preserve vas-
cular continuity, with uniformly poor results. Arthur
Blakemore of the Columbia Presbyterian Medical
Center in New York resurrected a previously
described method for the introduction of wire and
application of an electrical current to induce throm-
bosis of the aortic aneurysm sac.12-14 In 1938, he
reported wire insertion in 11 patients who had tho-
racic or abdominal aortic aneurysms; most eventual-
ly died of aneurysm rupture, but one patient sur-
vived for 2 years.15 In the same period, other sur-
geons used a variety of materials to wrap aneurysms
in an effort to retard expansion or to induce periar-
terial fibrosis, which might secondarily serve to
arrest enlargement. Cellophane wrapping was inves-
tigated by Pearse,16 Harrison and Chandy,17 and
Abbott.18 Other materials, including fascia lata, skin,
and polyvinyl sponge, were also used, but largely to
no avail because the aneurysms grew relentlessly
despite circumferential wrapping.19-21 Even after
prosthetic graft materials later became available, we
found at Emory that the wrapping method was no
match for the lateral pressure exerted by an expand-
ing aneurysm.22
But to drop back to other so-called alternative
techniques, some surgeons had chosen the more
direct approaches of ligation or banding of the aorta
or the tangential excision of suitable saccular
aneurysms. Halsted was an advocate of banding. He
banded the aorta for control of a painful aneurysm
in 1910, only to have the patient die 6 weeks later
when the band eroded the aorta.3 As early as 1936,
Leriche advocated terminal aortectomy and bilateral
lumbar sympathectomy for treatment of aortic
occlusive disease, in the belief that thrombus in the
aortic lumen tended to migrate and also that throm-
bus incited an inflammatory response with peripher-
al vasoconstriction.11 Dan Elkin and Fred Cooper of
Atlanta described a limited experience with this
treatment.23 Geza de Takats of Chicago summarized
the cases of 37 patients who had undergone total
aortic ligation over the preceding century, only eight
of whom had survived for 6 months or longer.20 In
general, the prevailing attitude concerning aortic
surgery was quite pessimistic, as reflected in I. A.
Bigger’s address to the American Surgical
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Association in 1940: “Judging from the literature,
only a small number of surgeons have felt that direct
surgical attack on aneurysms of the abdominal aorta
was justifiable, and it must be admitted that the
results obtained by surgical intervention have been
discouraging.”24
The experiences of World War II did little to
advance the cause of aortic surgery, but enthusiasm
increased somewhat in 1944 when Alexander and
Byron of Ann Arbor reported the first successful
proximal and distal ligation of the thoracic aorta for
removal of a fusiform aneurysm.25 In the same year,
Clarence Crafoord of Sweden successfully resected
and performed an end-to-end reanastomosis for
coarctation of the thoracic aorta, another important
foundation stone in the edifice of vascular surgery.26
Crafoord’s feat was repeated in this country the fol-
lowing year by Robert Gross of Boston.27 Harris
Shumacker, then of New Haven, Conn., performed
a similar successful resection and reanastomosis in
1947, after his release from military duty.28 It should
be noted that Charles Hufnagel of Washington,
D.C., experimented with permanent intubation of
the thoracic aorta with rigid tubes of methacrylate,
but results were marred by frequent erosion of the
vessel.29 Denton Cooley and Michael DeBakey of
Houston successfully performed lateral aortorrha-
phy of a saccular aneurysm of the thoracic aorta, and
Henry Bahnson of Baltimore affirmed the efficacy of
that approach in highly selected patients.30,31 At that
juncture, it was obvious that further progress would
not be possible without a suitable flexible conduit to
replace resected segments of the thoracic or abdom-
inal aorta. Once again, Robert Gross deserves cred-
it as a major innovator, because he was the first to
use harvested, preserved homografts for treatment
of coarctation of the aorta and to establish an aorta-
to-pulmonary artery shunt for alleviation of tetralo-
gy of Fallot.32,33 By his contributions, the modern
era of vascular grafting began.
Two years later, in 1950, Jacques Oudot of Paris
performed the first resection and homograft replace-
ment of a thrombosed aortic bifurcation, fulfilling
the prophecy of his fellow countryman Leriche 27
years earlier.34 The following year, Charles Dubost
and associates, also of France, treated an infrarenal
abdominal aortic aneurysm by insertion of a thoracic
aortic homograft that had been preserved for 3
weeks: “Three months after the operation the
patient was in perfect health.”35 DeBakey and
Cooley performed the first similar case in this coun-
try 1 year later, only days after Brock’s first repair in
Britain.36,37 Soon thereafter, Brock described the
arduous state of aortic surgery: “These cases are
long, anxious, tiring, one might even say exhaust-
ing....”37 It should also be noted that during that
period Charles Rob and Felix Eastcott were actively
involved in developing the first frozen human artery
bank at St. Mary’s Hospital in London.
Ormand Julian and associates of Chicago suc-
cessfully operated on an occluded aorta with homo-
graft insertion in 1952.38 Henry Bahnson is credit-
ed with the first successful repair of a ruptured aor-
tic aneurysm in 1953.3 Thereafter, enthusiasm for
homografts swelled over the next decade but then
waned because of frequent degeneration of the
grafts, as well as difficulty with the harvesting and
banking of the grafts.39-41 Gross had acknowledged
in a preliminary report that the short-term results of
human homograft implantation, up to 3 years, had
been gratifying but that “no final conclusion should
be made until these patients have been followed for
several decades.”42 In a summary report of extensive
experience with arterial homografts, Szilagyi and
colleagues observed serious deterioration of struc-
tural integrity over time and predicted their failure as
a vascular substitute.43
It was exactly in this period that Arthur Voorhees
made his momentous contribution to the founda-
tion being laid in our specialty.1 Art had completed
a straight internship in surgery at Presbyterian
Hospital in 1947 and remained an additional year to
work in the research laboratory of Arthur Blakemore
while awaiting an assignment at the Brooke Army
Medical Center to begin the following year. Under
Blakemore’s direction, Art was assigned the difficult
task of developing a mitral valve replacement in a
canine model. In the absence of cardiopulmonary
bypass, the procedure was technically demanding,
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Fig. 1. Existing wall of the old city of Jerusalem stands on
a foundation of previous fortifications.
requiring blind placement of silk support sutures to
function as “chordae tendinae” for the homograft
valve. In the spring of 1948, while performing an
autopsy on one of the animals several months after
valve implantation, Art noticed that a silk suture
bridging the ventricular cavity was coated with a
glistening layer of what appeared to be endocardi-
um. In a moment of inspiration, he speculated that
“a piece of cloth might react in a similar way.”44
Later, he wrote: “As an outgrowth of this observa-
tion it was conceived that if arterial defects were
bridged by prostheses constructed of a fine mesh
cloth, leakage of blood through the walls of the
prosthesis would be terminated by the formation of
fibrin plugs and would thus allow the cloth tube to
conduct arterial flow.”45 Art acknowledged that he
was not aware at that time of Guthrie’s suggestion
30 years earlier that an implant need serve only as
scaffolding for ingrowth of host tissue.46 Evidently,
he was also unaware of the earlier reports by Dorfler
in Germany and Carson in the United States that silk
sutures in the lumen of an artery sometimes became
encapsulated by a fine veil coating.47,48 Of course,
none of these earlier observers had made the epochal
leap from an interesting experimental observation to
the concept of a fabric tube, as proposed by
Voorhees. His first effort in the animal laboratory
using a conduit fashioned from his wife’s silk hand-
kerchief was only partially successful. Then during
his 2-year tour at the Surgical Research Unit in San
Antonio, Tex., Art performed a limited number of
experiments using nylon parachute cloth as an aortic
prosthesis. From that experience he concluded:
“The cloth had to be strong, inert, stable, of the
right porosity, supple, and yet easily traversed by a
fine needle.”44
Upon returning to Presbyterian Hospital in
1950 to begin his surgical residency, Art resumed
his work on vascular grafts in Blakemore’s labora-
tory. Following advice from an orthopaedic resi-
dent, Wallace Blunt, Art secured a bolt of Vinyon-
N fabric from the Union Carbon and Carbide
Corporation. The plastic material, Vinyon-N, had
been designed to be used as sail cloth but had
proved too inert to hold a dye and thus had no
commercial value. Art found it quite suitable for his
experiments, however, in which he prepared a vari-
ety of straight tube grafts on Margaret’s sewing
machine and then sutured them into the abdominal
aortas of mongrel dogs. Early implantations were
demanding and tedious: “We were often hard
pressed to separate our technical ineptitude, the
perversity of our handcrafted materials, and the
variations of host response, in analyzing our end
results.”49 By the end of 1950, implants had been
performed in 30 dogs, three quarters of which sur-
vived the operative procedure. Animals were killed
according to a predetermined schedule ranging
from hours to months, and eventually up to 8 years,
to provide a portrayal of graft healing. By the mid-
dle of 1951 there were sufficient data to prepare an
optimistic preliminary report that was published in
the Annals of Surgery in March 1952: “The use of
tubes constructed from Vinyon “N” cloth in bridg-
ing arterial defects,” coauthored by Voorhees,
Jaretzki, and Blakemore.45 Later that year, when
Art was a senior resident, the first synthetic graft
implantation was performed in a patient with a rup-
tured abdominal aortic aneurysm.50 Blakemore had
planned to use an aortic homograft, but because
none was available Art prepared a bifurcated graft
of Vinyon cloth. Although the patient died of coag-
ulopathy, the graft was intact and patent at autopsy,
providing sufficient encouragement to implant a
graft in a second patient electively a few weeks later;
the patient survived. Over the following year, 16
additional aneurysms were similarly treated, with an
impressive 56% survival rate.51 At about the same
time, Harris Shumacker successfully repaired a rup-
tured abdominal aortic aneurysm with a conduit
prepared from a sheet of nylon.52 To fully appreci-
ate the achievements of that era, one must under-
stand that hemostasis was a constant challenge both
because of the variability of fabrics and because of
the misconception that aneurysms had to be com-
pletely excised to avoid contamination.38,53 The
early grafts frequently leaked from their home-sewn
seams or frayed at the cut ends, which prompted
Voorhees and others to heat-seal the ends or to
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Fig. 2. An Islamic mosque has been constructed on the
ruins of the ancient temple at Luxor, Egypt.
turn back the grafts, French-cuff style, to facilitate
suturing.
In March 1954 Art reviewed the Presbyterian
data at a Symposium on Vascular Transplants spon-
sored by the National Research Council.54 Panelists
included Robert Gross, Charles Hufnagel, Harris
Shumacker, and Michael DeBakey. It was evident
that a new era had indeed begun in vascular surgery.
One month later, Blakemore and Voorhees present-
ed both animal and human data at the American
Surgical Association meeting, which were published
later that same year in the Annals of Surgery.51 The
new field of vascular prostheses had been opened,
and it expanded rapidly under sponsorship of a num-
ber of influential American surgeons. Other pros-
thetic materials were introduced by the industry, and
surgical meetings and journals during that time
focused on textile lexicon, debating the relative mer-
its of porosity, denier, taffeta, crimp, and other ele-
ments of fiber fabrication.55 Vinyon-N rapidly gave
way to competitive fibers with more favorable phys-
ical properties, including Orlon, Teflon, nylon, and
Dacron.56-59 Although vascular surgeons were key
to these developments, we must acknowledge that
industrial entrepreneurs and textile engineers were
important collaborators. In the early days of vascular
graft insertion, the materials were not custom-made
for use as medical devices; the yarns used and most
of the early conduits were, in fact, “borrowed” from
commercial textile applications. Voorhees lamented
the absence of industrial support for development in
the initial phase: “Materials were procured wherever
they could be found; tubes were cut and sewn in
scrub rooms...unsophisticated, often cranky, proto-
types...”60 (Fig. 3).
Michael DeBakey and associates in Houston
rapidly became the leading advocates of Dacron, a
fabric well established in the garment industry. In
cooperation with Professor Thomas Edman of the
Philadelphia College of Textiles and Science,
DeBakey sponsored the development of a knitting
machine capable of producing seamless knitted
Dacron tubes in various sizes and in the form of
bifurcations.61 Within less than 4 years, he and his
colleagues at Baylor had implanted more than 1000
synthetic grafts with a 90% success rate.62 One must
remember that progress could be made quickly in
those days in the development of new devices
because the pioneers were not handicapped by Food
and Drug Administration oversight or by the threat
of legal entanglements at every turn. In 1960 the
U.S. Catheter and Instrument Company began pro-
duction of DeBakey grafts; eventually, C.R. Bard,
Inc., took over the manufacture and distribution of
DeBakey grafts worldwide.63 Twelve years later,
Bard also introduced the first version of a filamen-
tous velour prosthesis, designed by Lester Sauvage
of Seattle.64
Sterling Edwards, another name synonymous
with early vascular graft innovations, heard
Voorhees’ paper at the American Surgical Asso-
ciation meeting and, back in Alabama, developed a
relationship with James Tapp, a physical chemist at
the Chemstrand Corporation.65,66 It was Tapp who
introduced the concept of crimping cylindrical grafts
to allow greater flexibility without kinking and to
provide better handling characteristics.67 The
Edwards-Tapp braided nylon graft was fabricated by
U.S. Catheter and Instrument Corp., headed by
Norman Jeckel.68 Eventually, Edwards switched his
preference from nylon to Teflon, because the latter
had shown superior tensile strength in studies
reported by Harold Harrison of Atlanta; Teflon
prostheses remained commercially available until
1979.69,70 Edwards in more recent years told
Andrew Dale: “You and I may have been tremen-
JOURNAL OF VASCULAR SURGERY
Volume 27, Number 1 Smith 11
Fig. 3. Arthur B. Voorhees, Jr., MD, in retirement (pro-
vided by Margaret R. Voorhees).
dously fortunate to have lived through the most
exciting era in surgery that there has ever been.”71
Ormond Julian of Chicago and Ralph Deterling
of New York collaborated with William von Liebig,
the general manager of Meadox Weaving
Corporation, an upholstery and drapery fabric man-
ufacturer in New Jersey, to design and produce fab-
ric grafts. Of that period, Deterling somewhat irrev-
erently declared: “It seemed almost heretical that
the introduction of cloth as a vascular replacement
allowed people with practically no background in
the field to go to Macy’s and ask a clerk, ‘What’s the
best thing for an aorta?’”72 He also astutely
observed: “The aggressiveness of the vascular sur-
geon is a tremendously important thing. The will-
ingness at the end of a hard day to go back and
repair a graft if it shows early failure is something
that separates the men from the boys.”73 From their
beginnings in 1954, the first woven grafts manufac-
tured by Meadox were distributed by the Ethicon
Division of Johnson & Johnson. By 1961, William
von Liebig emerged as the new owner, and Meadox
Medical, Inc., was launched, later to team also with
Denton Cooley in production of the graft line that
carries his name.74 Liebig credited erstwhile associ-
ate Walter Golaski of Philadelphia for a number of
important technical developments during the start-
up phase of Meadox grafts.75 Emerick Szilagyi,
working first with John Sidebotham of Philadelphia,
and later with Meadox, produced a woven Dacron
graft of specially elasticized yarn that proved to be
highly porous but quite efficacious, providing 97%
patency at 3 to 5 years after implantation of 286 aor-
toiliac grafts.76-79
A variety of other prosthetic materials and fabri-
cations were tried in those early years. Norman
Shumway et al. of Minneapolis experimented with
rolled sheets of polyvinyl sponge (Ivalon), and
Shumacker and colleagues of Indianapolis used lay-
ered nylon, incorporating a thin polyethylene film to
provide hemostasis.80,81 Allan Callow of Boston
called attention to the need for better control of the
manufacturing process of vascular grafts, while
Sterling Edwards warned that it was not feasible to
continue to tailor-make grafts—the industry had to
develop adequately tested, prefabricated tubes in a
variety of shapes and sizes.82,83 Deterling and
Bhonslay of New York summarized physical and
chemical data as well as in vivo experiments on a
wide range of fabrics in 1955, concluding that
“...Dacron appeared to have the most desirable qual-
ities in the overall evaluation.”84 Dacron, a polyester
polymer developed about 1939, had been intro-
duced in the United States by E. I. DuPont de
Nemours and Company, Inc., in 1946 and was
adapted to vascular applications 8 years later.85 It
consisted of a basic 70-denier yarn, 54 filaments to
the strand, texturized to provide bulk and elasticity.
In a report to the Society for Vascular Surgery meet-
ing in 1956, Oscar Creech, Chairman of a
Committee for the Study of Vascular Prostheses,
concluded that Dacron and Teflon were the most
satisfactory materials for use at that time, because
Vinyon-N was no longer commercially available and
because both nylon and Orlon exhibited significant
loss of tensile strength over time.86 Soon thereafter,
Sigmund Wesolowski of New York and coworkers
drew attention to the importance of porosity of syn-
thetic grafts, describing a method still in use today
to quantitate that characteristic by the volume of
water filtered per minute, per square centimeter of
fabric, at a pressure of 120 mm Hg.87 There have
been still other modifications of textile grafts over
the succeeding decades: alignment marks in the
grafts, internal and external velours, exterior rein-
forcement, tapered configuration, impregnation
with blood-tight barriers, antibiotic bonding, and
efforts to achieve antithrombogenic surfaces.88,89
Henry Haimovici of New York may have put these
modifications into proper perspective, however,
when he emphasized that host factors ultimately may
be more difficult to overcome than to achieve an
ideal vascular graft.90 He predicted: “Expanded use
of vascular replacements will take place and will
depend on three major factors: (1) improvement in
grafting material; (2) proper selection of patients for
surgery; and (3) adjuvant prophylactic treatment of
atherosclerosis.”91 Art Voorhees, also, had recog-
nized the limitations of the outflow system of the
host and challenged us to address the issue of angio-
genesis:
“I believe that our focus in vascular research should
now center on improving the flow of blood to the arteri-
oles and the capillary bed; not only as we do presently by
increasing pressure in the distributing artery, but also by
increasing the volume of the outflow tract. Why can’t we
unlock the secret of the blood-vessel proliferation of a cap-
illary hemangioma, the rapid collateralization of arteries in
the child, or the succulent plethora of blood vessels where
portal and systemic blood meet in a patient with portal
hypertension? Our thrust for research and development
should not be arrested by the quest for an ideal replace-
ment for the arterial delivery system alone”49 (Fig. 3).
Looking back over the phenomenal accomplish-
ments of the first decade of modern vascular surgery,
Hufnagel observed: “Only to the few is given the
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great gift of perception which permits them to intro-
duce and demonstrate the feasibility of new ideas.”92
In closing, allow me to mention one cautionary
note. Just when vascular surgeons had become com-
fortable with the durability and availability of
Dacron prostheses, we were shocked to hear that the
future supply of the raw material is threatened.
Dupont, the solitary source of Dacron for 50 years,
has withdrawn the textile from medical use as a
result of product liability issues. Although the graft
applications of Dacron appear to have constituted
only a small fraction of Dupont’s total market, inor-
dinate business expenses for legal defense of the
material were cited as the rationale for withdrawing
the product. It is said that the major graft makers
presently have only a 3-year stockpile of Dacron yarn
with which to continue to manufacture grafts. At
that point, they will have to switch to alternate
sources of polyester. We have been assured by the
industry, however, that other raw material sources
have been identified and that surgeons will not dis-
cern any difference in the quality of the new grafts.
One can only hope that their predictions are true.
Meanwhile, an agency called The Alliance of
Patients, Physicians, and Industry for Access to
Medical Devices has urged Congress to address bio-
materials shortages and other related tort reform
issues. As you know, biomaterials legislation was
incorporated into a broader product liability bill that
was passed by Congress last year but vetoed by the
President. With the current Congress, the
Biomaterials Access Assurance Act has been redraft-
ed by Representative George W. Gekas (R-Pa.). The
surgical community remains hopeful that for the
benefit of our patients acceptable legislation will pass
and be enacted.
Sincere thanks are extended to Shirley Franks for her
secretarial support and to Cathy Alden for editorial ser-
vices in preparation of the manuscript.
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